Btcp Pharma Company Profile
What is the competitive landscape for BTCP PHARMA
BTCP PHARMA has two approved drugs.
There are eleven US patents protecting BTCP PHARMA drugs.
Summary for Btcp Pharma
| US Patents: | 11 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
| Patent Litigation for Btcp Pharma: | See patent lawsuits for Btcp Pharma |
Drugs and US Patents for Btcp Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Btcp Pharma | SUBSYS | fentanyl | SPRAY;SUBLINGUAL | 202788-006 | Aug 30, 2012 | DISCN | Yes | No | 9,642,797 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Btcp Pharma | SUBSYS | fentanyl | SPRAY;SUBLINGUAL | 202788-003 | Jan 4, 2012 | DISCN | Yes | No | 8,486,972 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Btcp Pharma | SUBSYS | fentanyl | SPRAY;SUBLINGUAL | 202788-002 | Jan 4, 2012 | DISCN | Yes | No | 9,241,935 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Btcp Pharma | SUBSYS | fentanyl | SPRAY;SUBLINGUAL | 202788-005 | Jan 4, 2012 | DISCN | Yes | No | 9,642,844 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Btcp Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Btcp Pharma | LAZANDA | fentanyl citrate | SPRAY, METERED;NASAL | 022569-002 | Jun 30, 2011 | 9,078,814 | ⤷ Start Trial |
| Btcp Pharma | LAZANDA | fentanyl citrate | SPRAY, METERED;NASAL | 022569-001 | Jun 30, 2011 | 9,078,814 | ⤷ Start Trial |
| Btcp Pharma | LAZANDA | fentanyl citrate | SPRAY, METERED;NASAL | 022569-002 | Jun 30, 2011 | 8,216,604 | ⤷ Start Trial |
| Btcp Pharma | LAZANDA | fentanyl citrate | SPRAY, METERED;NASAL | 022569-002 | Jun 30, 2011 | 9,814,705 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for BTCP PHARMA drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Sublingual Spray | 0.4 mg/spray | ➤ Subscribe | 2017-05-22 |
International Patents for Btcp Pharma Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Africa | 201305355 | ⤷ Start Trial |
| Portugal | 1976521 | ⤷ Start Trial |
| Japan | 5241514 | ⤷ Start Trial |
| Slovenia | 1976521 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Btcp Pharma Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1635783 | CA 2014 00016 | Denmark | ⤷ Start Trial | PRODUCT NAME: FENTANYL I EN HVILKEN SOM HELST AF DE FORMER, DER ER BESKYTTET AF GRUNDPATENTET; REG. NO/DATE: EU/1/10/644/001-006 20100831 |
| 0901368 | C300523 | Netherlands | ⤷ Start Trial | PRODUCT NAME: FENTANYL; REGISTRATION NO/DATE: EU/2/11/127/001 20111006 |
| 0836511 | 122006000022 | Germany | ⤷ Start Trial | PRODUCT NAME: TRANSDERMAL IONTOPHORETISCH VERABREICHTES FENTANYL-HYDROCHLORID; REGISTRATION NO/DATE: EU/1/05/326/001 20060126 |
| 1769785 | C300521 | Netherlands | ⤷ Start Trial | PRODUCT NAME: FENTANYL; REG NO/DATE: EU/2/11/127/001 20111006 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
